The LSU AgCenter selects a vendor for the medical marijuana program. Chancellor Dr. Bill Richardson says this is the last major hurdle to getting the drug into the hands of those who need it.
He says the details of the agreement have not been released, but the plan is to contract with a Las Vegas research company called GB Sciences.
“This is a new experience for all of us. So we’re really monitoring as we go along. We’re real pleased with where we are now. We think we’ve got a good bidder to work with,” Richardson said.
Richardson says the Board of Supervisors will act on the plan at their June 22 meeting. He says it’s been almost a year since the board voted to allow the AgCenter to grow medical marijuana that would be prescribed to a certain group of patients outlined by state law.
“Almost a year to the day we’ll come back with a contract. It’s been a long year, longer than I would like, but still I think it’s been necessary,” Richardson said, “We had to make sure this was done right. We don’t get a second chance at it.”
Richardson says they hope to have the product available to the patients by early 2018. He says LSU will be on the cutting edge of medical marijuana research, and they’ll be able to help patients with cancer, epilepsy, or HIV/AIDS.
“Of course the bottom line for all of us was we think we can help improve the quality of some people’s lives,” Richardson said, “What I like about it is we’re the first university to be doing this, and so we hope we can be the role model for what happens in other states.”